8-K/A filed September 24, 2021, 7:59 PM ET ticker WHWK CIK 0001422142

other material confidence medium sentiment neutral materiality 0.50

Aadi Bioscience files historical audited financials of acquired private company showing $32.6M deficit

Whitehawk Therapeutics, Inc.

Old Aadi reported net loss of $3.5M for 2020, revenue of $14.6M (primarily $14M license revenue).
Accumulated deficit of $32.6M as of Dec 31, 2020; cash and equivalents of $4.5M.
Auditor's report includes substantial doubt about going concern due to recurring losses and negative cash flows.
As of Dec 31, 2020, the company had $14.3M payable to related party Celgene and $9M convertible promissory notes.
Merger with Aadi Bioscience, Inc. closed Aug 26, 2021; these are the acquired entity's historical financials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.